Brief: Axovant Gene Therapies Files For Proposed Mixed Shelf Offering Of Up To $750 Mln
Jan 10 (Reuters) - Axovant Gene Therapies Ltd AXGT.O :
* AXOVANT GENE THERAPIES LTD - FILES FOR PROPOSED MIXED
SHELF
OFFERING OF UP TO $750 MILLION - SEC FILING
Source text: [http://bit.ly/2sc79Fx]
Further company coverage: AXGT.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Sio Gene Therapies
See all newsBrief: Sio Gene Therapies Inc - On March 14, Got Notice That Nasdaq Has Determined That Company's Common Stock Will Be Delisted From Nasdaq Capital Market
Brief: Sio Gene Therapies Announces Fiscal Third Quarter 2022 Financial Results
Brief: Sio Gene Therapies Inc. Announces Board Approval Of Plan Of Complete Liquidation, Dissolution
Brief: Sio Gene Therapies Announces Second Quarter Financial Results
Brief: Sio Gene Therapies Announces Fiscal First Quarter 2022 Financial Results